FI954499A0 - Menetelmä ja analyysi - Google Patents

Menetelmä ja analyysi

Info

Publication number
FI954499A0
FI954499A0 FI954499A FI954499A FI954499A0 FI 954499 A0 FI954499 A0 FI 954499A0 FI 954499 A FI954499 A FI 954499A FI 954499 A FI954499 A FI 954499A FI 954499 A0 FI954499 A0 FI 954499A0
Authority
FI
Finland
Prior art keywords
pct
sec
date
human
subject
Prior art date
Application number
FI954499A
Other languages
English (en)
Swedish (sv)
Other versions
FI954499A (fi
FI113206B (fi
Inventor
Nils Olav Solum
Frank Brosstad
Paol Andre Holme
Geir Olav Gogstad
Original Assignee
Nycomed Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10732620&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI954499(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nycomed Pharma As filed Critical Nycomed Pharma As
Publication of FI954499A publication Critical patent/FI954499A/fi
Publication of FI954499A0 publication Critical patent/FI954499A0/fi
Application granted granted Critical
Publication of FI113206B publication Critical patent/FI113206B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/86—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving blood coagulating time or factors, or their receptors

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Saccharide Compounds (AREA)
  • Analysing Materials By The Use Of Radiation (AREA)
  • Diaphragms For Electromechanical Transducers (AREA)
  • Medicinal Preparation (AREA)
  • Telephone Function (AREA)
  • Holo Graphy (AREA)
FI954499A 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus FI113206B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9306053 1993-03-24
GB939306053A GB9306053D0 (en) 1993-03-24 1993-03-24 Method and assay
GB9400592 1994-03-23
PCT/GB1994/000592 WO1994022018A1 (en) 1993-03-24 1994-03-23 Method and assay

Publications (3)

Publication Number Publication Date
FI954499A FI954499A (fi) 1995-09-22
FI954499A0 true FI954499A0 (fi) 1995-09-22
FI113206B FI113206B (fi) 2004-03-15

Family

ID=10732620

Family Applications (1)

Application Number Title Priority Date Filing Date
FI954499A FI113206B (fi) 1993-03-24 1995-09-22 Tiettyjen hemostaattisten häiriöiden diagnoosimenetelmä ja testipakkaus

Country Status (13)

Country Link
US (1) US5811250A (fi)
EP (1) EP0694168B2 (fi)
JP (1) JP3422491B2 (fi)
AT (1) ATE154847T1 (fi)
AU (1) AU691489B2 (fi)
CA (1) CA2158363C (fi)
DE (1) DE69403961T3 (fi)
DK (1) DK0694168T4 (fi)
ES (1) ES2103582T5 (fi)
FI (1) FI113206B (fi)
GB (1) GB9306053D0 (fi)
NO (1) NO953770L (fi)
WO (1) WO1994022018A1 (fi)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5763199A (en) * 1994-09-29 1998-06-09 Mount Sinai School Of Medicine Of The City University Of New York Platelet blockade assay
NO20031431D0 (no) * 2003-03-28 2003-03-28 Forskningsparken As Metode for å diagnostisere hemostatiske forstyrrelser ved bruk av mikrovesikler fra blodplater
ES2571929T3 (es) * 2004-05-26 2016-05-27 Region Nordjylland Procedimiento para determinar la cantidad de CD36 circulante
US8563328B2 (en) * 2004-07-26 2013-10-22 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
WO2006088976A2 (en) * 2005-02-16 2006-08-24 University Of Louisville Research Foundation, Inc. Fiber-optic biosensor and biosensing methods
CA2712834A1 (en) * 2007-02-05 2008-08-14 Aarhus Universitet A method for diagnosing atherosclerotic plaques by measurement of cd36
US20090104649A1 (en) 2007-06-11 2009-04-23 Garovic Vesna D Markers for preeclampsia
EP3708682B1 (en) * 2008-02-01 2022-11-23 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of medical diseases and conditions
IT1398680B1 (it) * 2009-06-12 2013-03-08 Bios Internat S R L Metodo in vitro per la determinazione della proteina gp91phox come marker di stress ossidativo
EP2475988B1 (en) 2009-09-09 2018-11-14 The General Hospital Corporation Use of microvesicles in analyzing nucleic acid profiles
EP3865590B1 (en) 2009-09-09 2024-04-10 The General Hospital Corporation Use of microvesicles in analyzing kras mutations
WO2011063324A2 (en) * 2009-11-20 2011-05-26 The General Hospital Corporation Microfluidic systems for isolating microvesicles
EP2517014B1 (en) 2009-12-21 2014-11-19 Mayo Foundation For Medical Education And Research Early marker of proteinuria in patients treated with an anti-vegf treatment
JP5808349B2 (ja) 2010-03-01 2015-11-10 カリス ライフ サイエンシズ スウィッツァーランド ホールディングスゲーエムベーハー セラノーシスのためのバイオマーカー
US9469876B2 (en) 2010-04-06 2016-10-18 Caris Life Sciences Switzerland Holdings Gmbh Circulating biomarkers for metastatic prostate cancer
US20140045915A1 (en) 2010-08-31 2014-02-13 The General Hospital Corporation Cancer-related biological materials in microvesicles
EP2638057B1 (en) 2010-11-10 2019-03-06 Exosome Diagnostics, Inc. Method for isolation of nucleic acid containing particles and extraction of nucleic acids therefrom
CA3012985A1 (en) 2015-01-27 2016-08-04 Kardiatonos, Inc. Biomarkers of vascular disease

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5627036A (en) * 1989-12-27 1997-05-06 Boehringer Ingelheim International Gmbh Use of an anticoagulant as a diagnostic agent
US5266462A (en) * 1992-06-03 1993-11-30 Baxter Diagnostics Inc. Measurement of platelet activities

Also Published As

Publication number Publication date
DE69403961T3 (de) 2003-01-16
DK0694168T4 (da) 2002-09-30
NO953770D0 (no) 1995-09-22
CA2158363C (en) 2004-08-17
ATE154847T1 (de) 1997-07-15
DK0694168T3 (da) 1997-07-21
EP0694168A1 (en) 1996-01-31
AU6262794A (en) 1994-10-11
CA2158363A1 (en) 1994-09-29
FI954499A (fi) 1995-09-22
EP0694168B1 (en) 1997-06-25
US5811250A (en) 1998-09-22
JP3422491B2 (ja) 2003-06-30
JPH08509806A (ja) 1996-10-15
DE69403961D1 (de) 1997-07-31
DE69403961T2 (de) 1998-01-02
ES2103582T3 (es) 1997-09-16
GB9306053D0 (en) 1993-05-12
AU691489B2 (en) 1998-05-21
WO1994022018A1 (en) 1994-09-29
EP0694168B2 (en) 2002-06-12
NO953770L (no) 1995-09-22
ES2103582T5 (es) 2002-12-16
FI113206B (fi) 2004-03-15

Similar Documents

Publication Publication Date Title
FI954499A0 (fi) Menetelmä ja analyysi
DE3064061D1 (en) Test piece for measuring glucose
FI924396A0 (fi) Diagnostiska aemnen.
DE69328550D1 (de) Verwendung von fulleren-derivaten in diagnostischen und/oder therapeutischen mitteln
DE3851958D1 (de) VERFAHREN UND VORRICHTUNG ZUR BEHANDLUNG VON KöRPERLICHEN FLÜSSIGKEITEN.
BR9611909A (pt) Sistema de tratamento de água de ponto de utilização
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
NO950594D0 (no) Fremgangsmåte for diagnostisering og overvåking av sepsis
DE59705193D1 (de) Ventil für flüssigkeiten
HK1014207A1 (en) Method for quantifying extracellular bpi in body fluids
EP0870036A4 (en) MAMMALIAN SYNTHETIC ALPHA-N-ACETYLGLUCOSAMINIDASE AND GENE SEQUENCES ENCODING IT
ATE136940T1 (de) Diagnostische methode
DE69319127D1 (de) Konjugat für den Nachweis und/oder Quantifizierung von biologischen Komponenten
Jacobs et al. Treatment-outcome interactions
Finlay Facing up to acne
ATE167055T1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
DE69423796T2 (de) Testverfahren und Reagenz für Magnesium in menschlichen Körperflüssigkeiten
UA28749A (uk) Спосіб оцінки ефективності лікування гіпертонічної хвороби
RU97122225A (ru) Способ регуляции тканевых биологических барьеров, иммунитета и гомеостаза

Legal Events

Date Code Title Description
MA Patent expired